{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:29:05Z","timestamp":1790555345269,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijcrp.2021.200111","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T13:57:55Z","timestamp":1635429475000},"page":"200111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations \u2013 A review"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-7929","authenticated-orcid":false,"given":"A.A.L.","family":"Ajayi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.E.","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijcrp.2021.200111_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2021.200111_bib2","series-title":"WHO Global Brief on Hypertension 7","year":"2019"},{"issue":"50","key":"10.1016\/j.ijcrp.2021.200111_bib3","article-title":"Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis","volume":"94","author":"Sarki","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"9859","key":"10.1016\/j.ijcrp.2021.200111_bib4","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib5","first-page":"e29","article-title":"Heart disease and stroke statistics--2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib6","first-page":"507","article-title":"evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA. 2014"},{"issue":"10199","key":"10.1016\/j.ijcrp.2021.200111_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(19)30955-9","article-title":"The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1\u00b71 million adults","volume":"394","author":"Geldsetzer","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219623","article-title":"The impact of interventions for the primary prevention of hypertension in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"14","author":"Wamba","year":"2019","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.ijcrp.2021.200111_bib9","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1161\/CIRCULATIONAHA.105.539569","article-title":"Hypertension in sub-Saharan African populations","volume":"112","author":"Opie","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcrp.2021.200111_bib10","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1097\/HJH.0000000000002165","article-title":"Blood Pressure and burden of hypertension in Cameroon, a microcosm of Africa : a systematic review and meta-analysis of population based studies","volume":"37","author":"Defo","year":"2019","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004872-199301000-00014","article-title":"Spectrum of hypertensive heart disease in Nigerians: cross-sectional study of echocardiographic indices and their correlation with treadmill exercise capacity","volume":"11","author":"Ajayi","year":"1993","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-5273(97)00274-X","article-title":"Sudden unexpected death from cardiac causes in Nigerians: a review of 50 autopsied cases","volume":"63","author":"Rotimi","year":"1998","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib13","first-page":"141","article-title":"Explaining heart failure hyper-mortality in sub Saharan Africa: global genomic and environmental contribution review","volume":"112","author":"Ajayi","year":"2020","journal-title":"J. Natl. Med. Assoc."},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00004872-199407000-00017","article-title":"Epidemiological profile of hypertensive disease and renal risk factors in black Africa","volume":"12","author":"Laville","year":"1994","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002280050158","article-title":"Oral therapy with combined enalapril, prazosin and hydrochlorothiazide in the acute treatment of severe hypertension in Nigerians","volume":"51","author":"Ajayi","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-5273(98)00234-4","article-title":"Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate","volume":"67","author":"Adigun","year":"1998","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib17","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1016\/S2214-109X(18)30002-0","article-title":"As part of H3Africa Consortium. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study","volume":"6","author":"Owolabi","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"6","key":"10.1016\/j.ijcrp.2021.200111_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.2019.10575","article-title":"Association of midlife to late-life blood pressure patterns with incident dementia","volume":"13","author":"Walker","year":"2019","journal-title":"J. Am. Med. Assoc."},{"issue":"14","key":"10.1016\/j.ijcrp.2021.200111_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007988","article-title":"Cumulative incidence of hypertension by 55 Years of age in blacks and whites: the CARDIA study","volume":"11","author":"Thomas","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2362.1979.tb00898.x","article-title":"Abnormal cation composition and transport in erythrocytes from hypertensive patients","volume":"9","author":"Aderounmu","year":"1979","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijcrp.2021.200111_bib22","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI111894","article-title":"Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase","volume":"75","author":"Lasker","year":"1985","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib23","first-page":"199","article-title":"Differences in platelet calcium regulation between African Americans and Caucasians: implications for the predisposition of African Americans to essential hypertension","author":"Kimura","year":"1994","journal-title":"J. Hypertens."},{"issue":"3\u20134","key":"10.1016\/j.ijcrp.2021.200111_bib24","first-page":"139","article-title":"Plasma renin activity and plasma aldosterone concentrations in untreated Nigerians with essential hypertension","volume":"13","author":"Osotimehin","year":"1984","journal-title":"Afr. J. Med. Med. Sci."},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib25","first-page":"594","article-title":"Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups","volume":"91","author":"Rayner","year":"2001","journal-title":"S. Afr. Med. J."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211054","article-title":"Tafesse TB Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: a meta-analysis and systematic review","volume":"14","author":"Mengesha","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.CIR.99.1.90","article-title":"Attenuation of cyclic nucleotide- mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function","volume":"99","author":"Cardillo","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM199507203330304","article-title":"Wood AJ Attenuation of isoproterenol-mediated vasodilatation in blacks","volume":"333","author":"Lang","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijcrp.2021.200111_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/jhh.2017.18","article-title":"Recent advances in understanding hypertension development in sub-Saharan Africa","volume":"31","author":"Schutte","year":"2017","journal-title":"J. Hum. Hypertens."},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037145","article-title":"Adrenergic alpha-1 pathway is associated with hypertension among Nigerians in a pathway-focused analysis","volume":"7","author":"Reder","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0167-5273(94)90070-1","article-title":"Acute cardiovascular effects of the concurrent administration of enalapril, prazosin or amlodipine in healthy Nigerians","volume":"15","author":"Ajayi","year":"1994","journal-title":"Int. J. Cardiol."},{"issue":"96","key":"10.1016\/j.ijcrp.2021.200111_bib32","first-page":"111","article-title":"Evidence of synergism between ACE Inhibitors and alpha -1 antagonists during Isometric handgrip in normal man","volume":"25","author":"Sofowora","year":"1998","journal-title":"Cardiologe Tropicale : Tropical Cardiology"},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcmg.2016.07.012","article-title":"Ethnic difference in proximal aortic stiffness: an observation from the dallas heart study","volume":"10","author":"Goel","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004872-200501000-00023","article-title":"Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage","volume":"23","author":"Strain","year":"2005","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/ajh\/hpu193","article-title":"Racial differences in abnormal ambulatory blood pressure monitoring measures: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"28","author":"Muntner","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002284","article-title":"Prevalence of masked hypertension and its association with subclinical cardiovascular disease in African Americans: results from the Jackson heart study","volume":"5","author":"Redmond","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2215\/CJN.10131012","article-title":"Association of BP variability with mortality among African Americans with CKD","volume":"8","author":"McMullan","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.ijcrp.2021.200111_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/jhh.2013.33","article-title":"Visit-to-visit and 24-h blood pressure variability: association with endothelial and smooth muscle function in African Americans","volume":"27","author":"Diaz","year":"2013","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/0975-3583.85263","article-title":"Ambulatory blood pressure profile and left ventricular geometry in Nigerian hypertensives","volume":"2","author":"Ajayi","year":"2011","journal-title":"J. Cardiovasc. Dis. Res."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib40","first-page":"474","article-title":"Relationship between 24-hour blood pressure pattern and left ventricular structure and function in hypertensive Nigerians","volume":"23","author":"Nwafor","year":"2013","journal-title":"Ethn. Dis."},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib41","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00004872-199715055-00005","article-title":"Clinical relevance of optimal pharmacokinetics in the treatment of hypertension","volume":"15","author":"Meredith","year":"1997","journal-title":"J. Hypertens. Suppl."},{"issue":"11","key":"10.1016\/j.ijcrp.2021.200111_bib42","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/00004872-199816110-00016","article-title":"The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension","volume":"16","author":"Parati","year":"1998","journal-title":"J. Hypertens."},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib43","first-page":"458","article-title":"A therapeutic audit in the management of hypertension in Nigerians","volume":"66","author":"Oyewo","year":"1989","journal-title":"East Afr. Med. J."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.jhh.1001538","article-title":"Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs","volume":"17","author":"Adigun","year":"2003","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ijcrp.2021.200111_bib65","first-page":"519","article-title":"Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia","volume":"9","author":"Shukrala","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"11","key":"10.1016\/j.ijcrp.2021.200111_bib66","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.acvd.2011.08.002","article-title":"Hypertension management in an outpatient clinic at the institute of Cardiology of Abidjan (Ivory coast)","volume":"104","author":"Kramoh","year":"2011","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.ijcrp.2021.200111_bib67","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/17512433.2017.1371590","article-title":"Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications","volume":"10","author":"Mbui","year":"2017","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.ijcrp.2021.200111_bib68","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.jhh.1002080","article-title":"Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting","volume":"20","author":"Amira","year":"2006","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4314\/mmj.v29i2.7","article-title":"Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria","volume":"29","author":"Adejumo","year":"2017","journal-title":"Malawi Med. J."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pds.1035","article-title":"Pattern of drug utilization among hypertensives in a Nigerian teaching hospital","volume":"14","author":"Yusuff","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib71","first-page":"297","article-title":"Antihypertensive drug prescribing in a Tertiary hospital in Eastern Nigeria","volume":"11","author":"Ukwe","year":"2012","journal-title":"Trop. J. Pharmaceut. Res."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib72","first-page":"104","article-title":"Drug treatment for hypertension in a tertiary health care facility in Northern Nigeria","volume":"2","author":"Tamuno","year":"2011","journal-title":"Int. J. Pharm. Biomed. Res."},{"key":"10.1016\/j.ijcrp.2021.200111_bib73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/njc.njc_18_18","article-title":"Pattern and appropriateness of antihypertensive prescriptions among hospitalized hypertensive in Nigeria","volume":"16","author":"Akintunde","year":"2019","journal-title":"Nig. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib74","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/1596-3519.55665","article-title":"Prescription pattern of antihypertensive drugs in a tertiary health institution in Nigeria","volume":"7","author":"Etuk","year":"2008","journal-title":"Ann. Afr. Med."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5414\/CPP48068","article-title":"Antihypertensive drug utilization and conformity to guidelines in a sub-Saharan African hypertensive population","volume":"48","author":"Olanrewaju","year":"2010","journal-title":"Int. J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib76","first-page":"480","article-title":"Pattern of prescription of anti-hypertensive medications in a tertiary health care facility in Abuja, Nigeria","volume":"23","author":"Ojji","year":"2013","journal-title":"Ethn. Dis."},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib77","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4314\/njm.v17i3.37394","article-title":"Blood pressure control among treated hypertensives in a tertiary health institution","volume":"17","author":"Sani","year":"2008","journal-title":"Niger. J. Med."},{"issue":"17","key":"10.1016\/j.ijcrp.2021.200111_bib44","first-page":"672","article-title":"Comparison of the antihypertensive effect of enalapril and propranolol in black South Africans","volume":"67","author":"Goodman","year":"1985","journal-title":"S. Afr. Med. J."},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00558152","article-title":"Enalapril and hydrochlorothiazide in hypertensive Africans","volume":"36","author":"Ajayi","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib46","first-page":"163","article-title":"The efficacy of hydrochlorothiazide, timolol and enalapril in Ethiopians with essential hypertension","volume":"30","author":"Habpte","year":"1992","journal-title":"Ethiop. Med. J."},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib47","first-page":"324","article-title":"The effect of enalapril and prazosin on mild to moderate hypertension in black South Africans","volume":"80","author":"Venter","year":"1991","journal-title":"S. Afr. Med. J."},{"issue":"6","key":"10.1016\/j.ijcrp.2021.200111_bib48","first-page":"603","article-title":"Lack of effect of low doses of prazosin in hypertensive Nigerians","volume":"19","author":"Falase","year":"1976","journal-title":"Curr. Ther. Res. Clin. Exp"},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/jch.12891","article-title":"Influence of age and race on 24-hour ambulatory blood pressure responses to valsartan, hydrochlorothiazide, and their combination: implications for clinical practice","volume":"19","author":"Izzo","year":"2017","journal-title":"J. Clin. Hypertens."},{"issue":"6","key":"10.1016\/j.ijcrp.2021.200111_bib50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5830\/CVJA-2014-062","article-title":"Hypertension guideline working group; South African hypertension practice guideline 2014","volume":"25","author":"Seedat","year":"2014","journal-title":"Cardiovasc. J. Afr."},{"issue":"25","key":"10.1016\/j.ijcrp.2021.200111_bib51","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1901113","article-title":"Comparison of dual therapies for lowering blood pressure in black Africans","volume":"380","author":"Ojji","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib52","first-page":"485","article-title":"The efficacy and tolerability of amlodipine and hydrochlorothiazide in Nigerians with essential hypertension","volume":"87","author":"Ajayi","year":"1995","journal-title":"J. Natl. Med. Assoc."},{"issue":"5 Pt 1","key":"10.1016\/j.ijcrp.2021.200111_bib54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.amjhyper.2004.02.010","article-title":"Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry","volume":"17","author":"Libhaber","year":"2004","journal-title":"Am. J. Hypertens."},{"issue":"8","key":"10.1016\/j.ijcrp.2021.200111_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/10641963.2013.776570","article-title":"Efficacy of initiating therapy with amlodipine and hydrochlorothiazide or their combination in hypertensive Nigerians","volume":"35","author":"Iyalomhe","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib56","first-page":"532","article-title":"Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension","volume":"92","author":"Radevski","year":"2002","journal-title":"S. Afr. Med. J."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004872-200102000-00023","article-title":"European Study Investigators. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study","volume":"19","author":"Emeriau","year":"2001","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.114.05021","article-title":"Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects","volume":"65","author":"Roush","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ijcrp.2021.200111_bib59","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/HJH.0000000000001691","article-title":"Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis","volume":"36","author":"Roush","year":"2018","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ahj.2014.06.010","article-title":"The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial","volume":"168","author":"Vinereanu","year":"2014","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4314\/mmj.v29i2.6","article-title":"Monotherapy with amlodipine or hydrochlorothiazide in patients with mild to moderate hypertension: comparison of their efficacy and effects on electrolytes","volume":"29","author":"Nwachukwu","year":"2017","journal-title":"Malawi Med. J."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib62","first-page":"51","article-title":"Enalapril and hydrochlorothiazide combination in hypertensive diabetic Africans with proteinuria","volume":"2","author":"Ajayi","year":"1991","journal-title":"Practical Diabetes Digest"},{"issue":"7","key":"10.1016\/j.ijcrp.2021.200111_bib63","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/hc0702.104162","article-title":"Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients: results of the Baragwanath Trial","volume":"105","author":"Skudicky","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/jpp.JPP_140_16","article-title":"Ajayi AAL influence of West African ethnicity and gender on beta-cell function and Insulin sensitivity in essential hypertensives treated with hydrochlorothiazide and hydrochlorothiazide-lisinopril combination","volume":"8","author":"Olamoyegun","year":"2017","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"10","key":"10.1016\/j.ijcrp.2021.200111_bib78","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1464-5491.1992.tb01728.x","article-title":"A cross-sectional of echocardiographic indices, treadmill exercise capacity, and microvascular complications in Nigerian patients with hypertension associated with diabetes mellitus","volume":"9","author":"Babalola","year":"1992","journal-title":"Diabet. Med."},{"issue":"2","key":"10.1016\/j.ijcrp.2021.200111_bib79","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1056-8727(00)00069-6","article-title":"Prognostic indices for intrahospital mortality in Nigerian diabetic NIDDM patients. Role of gender and hypertension","volume":"14","author":"Kolawole","year":"2000","journal-title":"J. Diabet. Complicat."},{"issue":"22","key":"10.1016\/j.ijcrp.2021.200111_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5830\/CVJA-2010-086","article-title":"Achieving blood pressure goals study in uncontrolled hypertensive patients treated with a fixed dose combination of ramipril\/hydrochlorothiazide : the ASTRAL study","volume":"22","author":"Okpechi","year":"2011","journal-title":"Cardiovasc. J. Afr."},{"issue":"47","key":"10.1016\/j.ijcrp.2021.200111_bib81","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1093\/eurheartj\/ehy475","article-title":"Asleep blood pressure : significant prognostic marker of vascular risk and therapeutic target for prevention","volume":"39","author":"Hermida","year":"2018","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension : a single center retrospective study","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib83","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12872-018-0895-0","article-title":"Profile of patients with hypertensive urgency and emergency presenting to an urban emergency department of a tertiary referral hospital in Tanzania","volume":"18","author":"Shao","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2125.1986.tb05210.x","article-title":"Slow release nifedipine and atenolol as initial treatments in blacks with malignant hypertension","volume":"21","author":"Isles","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijcrp.2021.200111_bib85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/aam.aam_6_17","article-title":"A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria","volume":"16","author":"Olowofela","year":"2017","journal-title":"Ann. Afr. Med."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2125.2000.00207.x","article-title":"Angioedema and cough in Nigerian patients receiving ACE inhibitors","volume":"50","author":"Ajayi","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijcrp.2021.200111_bib93","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/jch.13974","article-title":"Frequency and factors associated with apparent resistant hypertension among Ghanaians in a multicenter study","volume":"22","author":"Ayisi -Boateng","year":"2020","journal-title":"J. Clin. Hypertens."},{"issue":"8","key":"10.1016\/j.ijcrp.2021.200111_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220710","article-title":"Prevalence of uncontrolled blood pressure in Meknes, Morocco, and its associated risk factors in 2017","volume":"14","author":"Essayagh","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib88","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.118.11308","article-title":"Initial hypertensive treatment strategies and therapeutic inertia","volume":"72","author":"Rea","year":"2018","journal-title":"Hypertension"},{"issue":"6\u20137","key":"10.1016\/j.ijcrp.2021.200111_bib89","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.acvd.2019.11.009","article-title":"Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension : cross-sectional study from 12 sub-Saharan countries","volume":"113","author":"Marquart de Terline","year":"2020","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib90","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.117.10512","article-title":"Socioeconomic status and hypertension control in sub Saharan Africa: the multination EIGHT study ( evaluation of hypertension in sub-Saharan Africa )","volume":"71","author":"Antignac","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcrp.2021.200111_bib91","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijcard.2017.04.099","article-title":"Fighting fake medicines : first quality evaluation of cardiac drugs in Africa","volume":"243","author":"Antignac","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcrp.2021.200111_bib92","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajh\/hpw167","article-title":"High frequency of variants of candidate genes in black Africans with low renin resistant hypertension","volume":"30","author":"Jones","year":"2017","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/HYPERTENSIONAHA.120.15064","article-title":"Adverse health outcomes associated with refractory and treatment resistant hypertension in the chronic renal insufficiency cohort","volume":"77","author":"Buhnerkempe","year":"2021","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ijcrp.2021.200111_bib95","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ajh\/hpx066","article-title":"Physiological phenotyping of uncontrolled hypertension in Africa","volume":"30","author":"Akintunde","year":"2017","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.ijcrp.2021.200111_bib96","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12916-020-01530-z","article-title":"Pharmacotherapy for hypertension in sub-Saharan Africa: a systematic review and network meta-analysis","volume":"18","author":"Seeley","year":"2020","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.ijcrp.2021.200111_bib97","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/HCO.0b013e3283474c20","article-title":"Is blood pressure control to less than 140\/less than 90 mmHg in 50% of all hypertensive patients, as good as we can do in the USA: or is this as good as it gets","volume":"26","author":"Egan","year":"2011","journal-title":"Curr. Opin. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcrp.2021.200111_bib98","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamainternmed.2018.0447","article-title":"Association of a smart phone with medication adherence and blood pressure control : the MediSAFE-BP randomized clinical trial","volume":"178","author":"Morawski","year":"2018","journal-title":"JAMA Int. Med."},{"key":"10.1016\/j.ijcrp.2021.200111_bib99","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/VHRM.S25743","article-title":"Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium channel blocker (CCB), and hydrochlorothiazide (HCTZ) versus dual therapy with an ARB and HCTZ","volume":"7","author":"Duprez","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"issue":"8","key":"10.1016\/j.ijcrp.2021.200111_bib100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/jhh.2017.5","article-title":"Triple-combination therapy in the treatment of hypertension : a review of the evidence","volume":"31","author":"Dusing","year":"2017","journal-title":"J. Hum. Hypertens."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487521000131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487521000131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:56:20Z","timestamp":1757415380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487521000131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":100,"alternative-id":["S2772487521000131"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2021.200111","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations \u2013 A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2021.200111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200111"}}